Isifer AB - Women's Health Medicine
Isifer has developed two innovative women’s health products based on a pioneering concept spun out of research at the Karolinska Institute in Sweden. The projects are based on the well known drug Lidocaine with two novel indications; endometriosis (Endole®) and infertility treatment (Isifera®).
The products, which are both administered through perturbation (flushing)
of the Fallopian tubes, have successfully undergone clinical phase studies which have respectively demonstrated proof of concept and favorable safety and tolerability profiles, with no side effects observed.
Isifer was founded in 2001 and is a privately held company.